drugset / Trial / NCT01456624
Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fasting and Fed Condition
RandomizedCrossoverOpen-labelSupportive care
Summary
The purpose of this study is to evaluate pharmacokinetics of Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in healthy male volunteers under fasting and fed condition.
Timeline
- Start
- 2011-09
- Primary completion
- 2012-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DW-ES(B) | Unknown | 625 mg | — |
| Comparator | Megestrol Acetate | Other / unclassified | 800 mg | — |
Indications
No indication recorded.